Literature DB >> 8202538

Specific T-cell tolerance may be preceded by a primary response.

L Vidard1, L J Colarusso, B Benacerraf.   

Abstract

We have evaluated the ability of ovalbumin to induce T-cell-specific tolerance in SJL mice. A significant decrease of interleukin 2 in lymph-node culture supernatants from tolerant mice upon antigen stimulation was seen. Oral tolerization was less effective than i.p.- or s.c.-tolerization protocols. Transfer experiments of either splenic or lymph-node T cells from tolerant mice to naive mice definitely ruled out suppression as a mechanism involved in tolerant mice. Surprisingly, we found that, before the establishment of specific T-cell tolerance to ovalbumin, T cells from mice that will display tolerance were responsive and synthesized interleukin 2 upon antigen challenge in vitro. Thus, we concluded that anergy cannot account solely for the T-cell unresponsiveness in tolerant mice. Furthermore, although we cannot rule out the hypothesis that the T-cell unresponsiveness in tolerant mice can be explained by programmed cell death of ovalbumin-specific T cells, these data led us to speculate that T-cell "refractoriness" could explain the drop of interleukin 2 production in lymph-node T-cell culture supernatant from tolerant mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202538      PMCID: PMC44049          DOI: 10.1073/pnas.91.12.5627

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit.

Authors:  P Pierre; O Denis; H Bazin; E Mbongolo Mbella; J P Vaerman
Journal:  Eur J Immunol       Date:  1992-12       Impact factor: 5.532

Review 2.  Revisiting and revising suppressor T cells.

Authors:  B R Bloom; P Salgame; B Diamond
Journal:  Immunol Today       Date:  1992-04

3.  Preliminary results corroborating the polygenic control of immunological tolerance.

Authors:  A C da-Silva; S Massa; O A Sant'Anna
Journal:  Braz J Med Biol Res       Date:  1990       Impact factor: 2.590

4.  Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells.

Authors:  D Moskophidis; F Lechner; H Pircher; R M Zinkernagel
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

5.  Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model.

Authors:  P Aichele; D Kyburz; P S Ohashi; B Odermatt; R M Zinkernagel; H Hengartner; H Pircher
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

6.  Decrease in susceptibility to oral tolerance induction and occurrence of oral immunization to ovalbumin in 20-38-week-old mice. The effect of interval between oral exposures and rate of antigen intake in the oral immunization.

Authors:  A M Faria; G Garcia; M J Rios; C L Michalaros; N M Vaz
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

7.  Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas.

Authors:  Y Shi; J M Glynn; L J Guilbert; T G Cotter; R P Bissonnette; D R Green
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

8.  Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin.

Authors:  D Melamed; A Friedman
Journal:  Eur J Immunol       Date:  1993-04       Impact factor: 5.532

9.  In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen.

Authors:  H J Burstein; A K Abbas
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

10.  Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.

Authors:  S J Khoury; W W Hancock; H L Weiner
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  9 in total

1.  Visualization of Cell-Cell Interaction Contacts: Synapses and Kinapses.

Authors:  Michael L Dustin
Journal:  Self Nonself       Date:  2011-04-01

2.  CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection.

Authors:  J X Gao; J Madrenas; W Zeng; M J Cameron; Z Zhang; J J Wang; R Zhong; D Grant
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

3.  Induction of abortive and productive proliferation in resting human T lymphocytes via CD3 and CD28.

Authors:  Y Müller; H Wolf; E Wierenga; G Jung
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

Review 4.  Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor.

Authors:  P Scheipers; H Reiser
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

Review 5.  Allergen immunotherapy with cat allergen peptides.

Authors:  A Barry Kay; Mark Larché
Journal:  Springer Semin Immunopathol       Date:  2003-09-30

6.  Specific T-cell tolerance may reflect selective activation of lymphokine synthesis.

Authors:  L Vidard; L J Colarusso; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

7.  Bolus injection of aqueous antigen leads to a high density of T-cell-receptor ligand in the spleen, transient T-cell activation and anergy induction.

Authors:  S K Switzer; B P Wallner; T J Briner; G H Sunshine; C R Bourque; M Luqman
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

8.  Oral tolerance in T cells is accompanied by induction of effector function in lymphoid organs after systemic immunization.

Authors:  Neetha Parameswaran; Devadoss John Samuvel; Ramesh Kumar; Sangeeta Thatai; Vineeta Bal; Satyajit Rath; Anna George
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

9.  T cell priming versus T cell tolerance induced by synthetic peptides.

Authors:  P Aichele; K Brduscha-Riem; R M Zinkernagel; H Hengartner; H Pircher
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.